MagPortal.com   Clustify - document clustering
 Home  |  Newsletter  |  My Articles  |  My Account  |  Help 
Similar Articles
The Motley Fool
February 3, 2005
Rich Duprey
Candela's Lasers Offer Dim View In the cosmetic laser maker's earnings report, it misses its estimates. Revenues, though within the range set by the company, were still at the bottom rung of the ladder at $28.2 million. mark for My Articles similar articles
The Motley Fool
February 17, 2005
Rich Duprey
Candela Does a Slow Burn Arbitrator rules against laser maker in royalty case. Already reeling from the lackluster sales of lasers that remove varicose veins, tattoos, and the like, Candela's stock plummeted another 10%. mark for My Articles similar articles
The Motley Fool
May 5, 2005
Rich Duprey
Candela Brightens on Sales Growth The laser manufacturer reports record revenues and growing profits. Though not a sell, this stock isn't as hot as expected. mark for My Articles similar articles
The Motley Fool
March 24, 2006
Rich Duprey
Honing In on Laserscope The medical-use laser manufacturer may get a boost from a laser deal with China. Investors, one deal does not a quarter make, but it could be signal that the tide is turning for this leading medical device laser manufacturer. mark for My Articles similar articles
The Motley Fool
April 10, 2007
Rich Duprey
The Beauty of Lasers With aesthetic laser treatments booming, which company looks the best? Candela... Cutera... Palomar Medical Technologies... Cynosure... Syneron... mark for My Articles similar articles
The Motley Fool
November 5, 2004
Rich Duprey
Profit From Management Integrity Laser manufacturer Candela's management avoids taking the easy way out to explain shortfalls. It's a sign of management integrity that will lead to future profits. mark for My Articles similar articles
The Motley Fool
April 24, 2008
Rich Duprey
Candela Fizzles Aesthetic laser maker Candela reports slightly higher revenue but wider-than-anticipated losses. mark for My Articles similar articles
The Motley Fool
March 15, 2007
Rich Duprey
Candela Eases the Pain The aesthetic laser maker acquires an innovative technology that minimizes pain. Investors, it's essentially an investment in the future, but one that still entails some risk. mark for My Articles similar articles
The Motley Fool
February 14, 2006
Rich Duprey
Cutera's Laser Woes Aesthetic laser maker has a cloudy future of lower sales, earnings, and patent lawsuits. Investors, take note. mark for My Articles similar articles
The Motley Fool
August 26, 2005
Rich Duprey
Candela Burns Holes in Logic The cosmetic laser manufacturer claims success via questionable mental gymnastics. Perhaps it ought to trim the fat off its verbiage and spare investors any more unneeded workouts. mark for My Articles similar articles
The Motley Fool
April 17, 2007
Rich Duprey
Foolish Forecast: A Bet Candela Can't Afford to Lose The aesthetic laser maker is set to report third-quarter 2007 financial results. Investors, here is what you can expect to see. mark for My Articles similar articles
The Motley Fool
April 25, 2007
Rich Duprey
Candela's Amazing Shrinking Quarter The aesthetic laser maker reports its second consecutive quarter of declining sales. Investors, take note. mark for My Articles similar articles
The Motley Fool
February 1, 2006
Rich Duprey
Candela Is Finally White Hot The aesthetic laser maker finally produces the white-hot sales growth it promised -- two years ago. In midday trading, the stock soared 30%. mark for My Articles similar articles
The Motley Fool
May 3, 2006
Rich Duprey
Candela's Cool Beam The aesthetic laser manufacturer reports steady revenues and profits. Candela's not a cheap stock at these prices, even with the sell-off. mark for My Articles similar articles
The Motley Fool
November 2, 2005
Rich Duprey
Can Candela Regain Focus? Aesthetic laser maker reports strong gains, but can it do so consistently? It has new products, new distributors, and new markets to expand into, along with a shareholder-friendly stock buyback program. mark for My Articles similar articles
The Motley Fool
April 3, 2007
Rich Duprey
Palomar Medical Burns Another Rival The aesthetic laser maker zaps a privately held firm for patent infringement. But one company not buckling under to Palomar's aggressive tactics is Candela. Investors, take note. mark for My Articles similar articles
The Motley Fool
January 24, 2007
Rich Duprey
Candela's Number Is Up The aesthetic laser maker reports dismal results that fall short of its own fuzzy math expectations. mark for My Articles similar articles
The Motley Fool
September 12, 2006
Rich Duprey
A Fuzzy Forecast for Candela Based on company-specific trends, the balance of 2006 will be a bust for the aesthetic laser maker. Investors, take note. mark for My Articles similar articles
The Motley Fool
January 10, 2006
Rich Duprey
Biolase Brightens Outlook The aesthetic laser company expects to be cash flow-neutral on flat revenues. Investors cheer. mark for My Articles similar articles
The Motley Fool
August 28, 2007
Rich Duprey
Candela's Chance to Fan the Flames The maker of lasers used in aesthetic procedures receives FDA approval for an innovative pain reduction technology. Investors, it needs something. Sales have been giving off a pretty weak signal lately, and management admits it has been losing market share. mark for My Articles similar articles
The Motley Fool
May 22, 2006
Rich Duprey
A Change of Heart for Candela An upgrade of the laser maker points out the futility of watching analysts' shifting opinions. One of the tricks to generating long-term profits is to ignore the shifting winds of analyst sentiment and focus solely on the ability of the company to deliver. mark for My Articles similar articles
The Motley Fool
September 10, 2007
Rich Duprey
A Strategic Alternative for Candela In an SEC filing, hedge fund Third Point LLC reports its discussions of "strategic alternatives" at laser maker Candela. Some say a sale was discussed. Investors should take notice. mark for My Articles similar articles
The Motley Fool
April 30, 2007
Rich Duprey
Foolish Forecast: Cutera Zaps Quarter Investors, don't expect the aesthetic laser maker to burn up the growth charts when it reports first-quarter results. mark for My Articles similar articles
The Motley Fool
May 2, 2007
Rich Duprey
Cynosure Sure Looks Good Aesthetic-laser maker reports record results on strength of new laser offerings. Investors, take note. mark for My Articles similar articles
The Motley Fool
October 26, 2006
Rich Duprey
Candela's October Surprise The aesthetic laser maker trounces analyst projections, though all may not be what it seems. Investors, take note. mark for My Articles similar articles
The Motley Fool
March 14, 2008
Rich Duprey
No Point Man at Candela Activist hedge fund Third Point cuts its stake in the aesthetic laser maker Candela from 9% to only 3.5%. mark for My Articles similar articles
The Motley Fool
January 17, 2007
Rich Duprey
Foolish Forecast: Dim Hope for Candela The aesthetic-laser maker will report second-quarter 2007 financial results shortly. Investors, here what to expect. mark for My Articles similar articles
The Motley Fool
August 18, 2006
Rich Duprey
Candela Singed by Patent Lawsuit The cosmetic laser maker, hit by rival's claim of infringement, fires back with a counterclaim. Investors, with Candela releasing its earnings report next week, this is sure to be a white hot topic on the conference call. Investors, take note. mark for My Articles similar articles
The Motley Fool
February 11, 2005
Stephen D. Simpson
Laser Beamer Lookin' Good Palomar continues to build a profitable business in the highly competitive cosmetic laser market. mark for My Articles similar articles
The Motley Fool
November 10, 2005
Stephen D. Simpson
Rofin-Sinar's Stock Lights Up Better-than-expected earnings boost the shares of this small laser maker. mark for My Articles similar articles
The Motley Fool
April 17, 2007
Rich Duprey
BioLase Darkens Smiles The dental laser maker warns that quarterly revenues will be dramatically lower. Investors, take note. mark for My Articles similar articles
The Motley Fool
December 14, 2010
Eric Jhonsa
Our Top 5 Tech Stocks For 2011: IPG Photonics The company's fiber lasers are gobbling up market share in a hurry. mark for My Articles similar articles
The Motley Fool
February 13, 2007
Rich Duprey
Palomar's Parallax View A plethora of one-time revenues skewed the aesthetic laser maker's results. Investors, take note. mark for My Articles similar articles
The Motley Fool
August 22, 2006
Rich Duprey
Candela Goes Dark Atop recent legal woes, the laser maker reports gloomy quarterly earnings. Investors, take note. mark for My Articles similar articles
The Motley Fool
May 8, 2007
Rich Duprey
Cutera's Ugly Quarter The aesthetic laser maker's weak domestic sales dim the outlook for the rest of the year. Investors, take note. mark for My Articles similar articles
The Motley Fool
February 7, 2005
W.D. Crotty
Rofin-Sinar's Searing Quarter Laser make's stock is down, even after announcing more blowout numbers. mark for My Articles similar articles
The Motley Fool
November 11, 2004
W.D. Crotty
Laser Targets True Gem Rofin-Sinar turns in a blowout quarter. With its rock-solid balance sheet and widening technology base, the industrial laser manufacturer is focused on growth and profits. mark for My Articles similar articles
The Motley Fool
January 20, 2005
Stephen D. Simpson
II-VI Gets Zapped The advanced electro-optics maker misses estimates and takes a hit. mark for My Articles similar articles
Military & Aerospace Electronics
December 2007
John Keller
Fiber Laser Sales to Grow 26 Percent Annually Through 2011 Many key questions remain, such as how fast and how much market share can kilowatt fiber lasers gain from carbon dioxide lasers in sheet metal cutting? And, how much vertical integration is necessary to succeed in the fiber laser market? mark for My Articles similar articles
The Motley Fool
April 22, 2008
Rich Duprey
Foolish Forecast: No Sizzle at Candela In advance of earnings, analysts expect sales from aesthetic laser maker Candela to be essentially flat. mark for My Articles similar articles
The Motley Fool
February 13, 2006
Stephen D. Simpson
Will Syneron Defy History? Publicly traded laser companies have a legacy of failure; will Syneron manage to turn that tide? mark for My Articles similar articles
The Motley Fool
May 9, 2007
Rich Duprey
BioLase's Dull Quarter The dental laser maker makes good on its promise of a disappointing quarter, but the future may be bright for investors. mark for My Articles similar articles
The Motley Fool
April 9, 2007
Rich Duprey
Cutera's Meltdown The maker of aesthetic lasers lowers guidance, and Mr. Market's reaction isn't surprising. mark for My Articles similar articles
The Motley Fool
January 31, 2008
Rich Duprey
Candela Investors Burned Again The aesthetic-laser maker continues its string of disappointing quarters. mark for My Articles similar articles
Health
December 2007
Lisa Lombardi
Gynos Removing Wrinkles? Health investigates how the cosmetic-surgery boom is changing the face of doctors' offices everywhere. mark for My Articles similar articles
The Motley Fool
November 11, 2008
Brian Orelli
Two Years of Red Aesthetic laser makers have been rocked over the last few years. mark for My Articles similar articles
The Motley Fool
April 21, 2005
Stephen D. Simpson
II-VI Hits the Mark Strong sales and good bookings suggest that the laser market is continuing to grow. mark for My Articles similar articles
The Motley Fool
October 5, 2005
Rich Duprey
Candela's Options Zap Profits The aesthetic laser-maker will capitalize on an accounting rule to accelerate options vesting. The company is basing its decisions not on what's best for business, but on how to make the accounting look good. That should give investors a lot to think about. mark for My Articles similar articles
The Motley Fool
September 19, 2005
Rich Duprey
Candela's Beam Not So Hot The laser maker delays filing its annual report as it searches for material weaknesses. Delays in filing its annual reports are head-shaking distractions to performance that investors just don't need. mark for My Articles similar articles
The Motley Fool
May 15, 2006
Stephen D. Simpson
Sales and Marketing Slam Syneron Higher expenses and disappointing results leave the med-tech stock suffering. mark for My Articles similar articles